Risk prediction for multi-station N2 metastases in patients with prior surgery for clinical single-station N2 non-small cell lung cancer
This study investigated the long-term prognosis of patients with clinically singular N2 NSCLC with 49.2% 5-year OS and 44.5% RFS. According to our results, patients with pN2b had a significantly worse prognosis than patients with pN2a1 and pN2a2, even some patients with cN2a NSCLC. Using preoperative clinical variables, we developed a risk scoring system to […]
